Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank
The Motley FoolThe company published some very good news from the lab, although it wasn’t so encouraging for smaller rivals.
The company published some very good news from the lab, although it wasn’t so encouraging for smaller rivals.